GURUFOCUS.COM » STOCK LIST » Basic Materials » Chemicals » AMINOLOGICS Co Ltd (XKRX:074430) » Definitions » Debt-to-Revenue

AMINOLOGICS Co (XKRX:074430) Debt-to-Revenue : 0.13 (As of Dec. 2024)


View and export this data going back to 2004. Start your Free Trial

What is AMINOLOGICS Co Debt-to-Revenue?

Debt-to-Revenue measures a company's ability to pay off its debt.

AMINOLOGICS Co's Short-Term Debt & Capital Lease Obligation for the quarter that ended in Dec. 2024 was ₩1,284 Mil. AMINOLOGICS Co's Long-Term Debt & Capital Lease Obligation for the quarter that ended in Dec. 2024 was ₩735 Mil. AMINOLOGICS Co's annualized Revenue for the quarter that ended in Dec. 2024 was ₩16,079 Mil. AMINOLOGICS Co's annualized Debt-to-Revenue for the quarter that ended in Dec. 2024 was 0.13.


AMINOLOGICS Co Debt-to-Revenue Historical Data

The historical data trend for AMINOLOGICS Co's Debt-to-Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

AMINOLOGICS Co Debt-to-Revenue Chart

AMINOLOGICS Co Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Debt-to-Revenue
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.10 0.07 0.07 0.09 0.12

AMINOLOGICS Co Quarterly Data
Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24
Debt-to-Revenue Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.06 0.11 0.10 0.22 0.13

Competitive Comparison of AMINOLOGICS Co's Debt-to-Revenue

For the Specialty Chemicals subindustry, AMINOLOGICS Co's Debt-to-Revenue, along with its competitors' market caps and Debt-to-Revenue data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


AMINOLOGICS Co's Debt-to-Revenue Distribution in the Chemicals Industry

For the Chemicals industry and Basic Materials sector, AMINOLOGICS Co's Debt-to-Revenue distribution charts can be found below:

* The bar in red indicates where AMINOLOGICS Co's Debt-to-Revenue falls into.


;
;

AMINOLOGICS Co Debt-to-Revenue Calculation

Debt-to-Revenue measures a company's ability to pay off its debt.

AMINOLOGICS Co's Debt-to-Revenue for the fiscal year that ended in Dec. 2024 is calculated as

Debt-to-Revenue=Total Debt / Revenue
=(Short-Term Debt & Capital Lease Obligation + Long-Term Debt & Capital Lease Obligation) / Revenue
=(1283.662 + 734.77) / 16790.273
=0.12

AMINOLOGICS Co's annualized Debt-to-Revenue for the quarter that ended in Dec. 2024 is calculated as

Debt-to-Revenue=Total Debt / Revenue
=(Short-Term Debt & Capital Lease Obligation + Long-Term Debt & Capital Lease Obligation) / Revenue
=(1283.662 + 734.77) / 16079.408
=0.13

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

In the calculation of annual Debt-to-Revenue, the Revenue of the last fiscal year is used. In calculating the annualized quarterly data, the Revenue data used here is four times the quarterly (Dec. 2024) Revenue data.


AMINOLOGICS Co Debt-to-Revenue Related Terms

Thank you for viewing the detailed overview of AMINOLOGICS Co's Debt-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.


AMINOLOGICS Co Business Description

Traded in Other Exchanges
N/A
Address
151, Yeoksamro, No. 301, 3rd Floor, Samo Building, Gangnam-gu, Seoul, KOR, 135-848
AMINOLOGICS Co Ltd engages in the manufacture and sale of amino acids and amino acid derivatives. The Amino Acid business division provides amino acid and amino acid derivative products as derivative serine, phenylalanine, alanine, allo-lle, and allo-threonine.

AMINOLOGICS Co Headlines

No Headlines